Inhibikase Therapeutics Inc. (IKT)
NASDAQ · Healthcare
Inhibikase Therapeutics Inc. Balance Sheet 2020–2024
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 98.6M | 14.5M | 24.9M | 42.5M | 14.8M |
| Cash & Equivalents | 97.5M | 9.2M | 7.2M | 40.8M | — |
| Liabilities | |||||
| Total Liabilities | 3.7M | 3.5M | 3.9M | 4.1M | 5.0M |
| Long-Term Debt | — | 381,784 | — | 248,911 | — |
| Equity | |||||
| Shareholders' Equity | 94.9M | 11.0M | 21.0M | 38.4M | 9.8M |
Inhibikase Therapeutics Inc. Balance Sheet — FAQ
Inhibikase Therapeutics Inc. (IKT) balance sheet over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IKT's balance sheet history?
The chart and table above show Inhibikase Therapeutics Inc.'s balance sheet by year and by quarter, including the growth rate.